|
ID |
DDInter1013 |
Drug Type |
small molecule |
Molecular Formula |
C19H24N2O3 |
Molecular Weight |
328.412
|
Description |
Labetalol is a racemic mixture of 2 diastereoisomers where dilevalol, the R,R' stereoisomer, makes up 25% of the mixture.[L7730] Labetalol is formulated as an injection or tablets to treat hypertension.[L7727,L7730]
Labetalol was granted FDA approval on 1 August 1984.[L7724]
|
ATC Classification |
C07BG01
C07CG01
C07AG01
|
IUPAC Name |
2-Hydroxy-5-{1-Hydroxy-2-[(4-Phenylbutan-2-Yl)Amino]Ethyl}Benzamide |
InChI |
Inchi=1S/C19H24N2O3/C1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/H2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24) |
InChI Key |
SGUAFYQXFOLMHL-UHFFFAOYSA-N |
Canonical SMILES |
CC(CCC1=CC=CC=C1)NCC(O)C1=CC(C(N)=O)=C(O)C=C1 |
Useful Links |
DrugBank
ChEMBL
|